Patents by Inventor Zhaoxia Yang

Zhaoxia Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND USES THEREOF
    Publication number: 20240067642
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: February 29, 2024
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • COMPOUNDS AND USES THEREOF
    Publication number: 20240002382
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230416246
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: December 28, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • Compounds and uses thereof
    Patent number: 11851445
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: December 26, 2023
    Assignee: FOGHORN THERAPEUTICS INC.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230331722
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: June 29, 2023
    Publication date: October 19, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • BRD9 degraders and uses thereof
    Patent number: 11787800
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: October 17, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton, Francois Brucelle
  • Methods and compounds for treating disorders
    Patent number: 11773085
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: October 3, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Qianhe Zhou, Michael Bocker, David Simon Millan, Ho Man Chan, Luis Soares, Matthew Russell Netherton, Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Francois Brucelle
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230142883
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: September 19, 2022
    Publication date: May 11, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Russell Netherton
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230077730
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 16, 2023
    Applicants: Foghorn Therapeutics Inc., Foghorn Therapeutics Inc.
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230072053
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 9, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230066136
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 2, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230065463
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 2, 2023
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • Compounds and uses thereof
    Patent number: 11560381
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: January 24, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton
  • COMPOUNDS AND USES THEREOF
    Publication number: 20220289711
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: July 31, 2020
    Publication date: September 15, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE
  • Compounds and uses thereof
    Patent number: 11414416
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: August 16, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton
  • COMPOUNDS AND USES THEREOF
    Publication number: 20220098190
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 31, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE, Rishi G. VASWANI
  • COMPOUNDS AND USES THEREOF
    Publication number: 20220048906
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: July 22, 2021
    Publication date: February 17, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • COMPOUNDS AND USES THEREOF
    Publication number: 20210230190
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: July 29, 2021
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT
  • METHODS AND COMPOUNDS FOR TREATING DISORDERS
    Publication number: 20210009568
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: July 29, 2020
    Publication date: January 14, 2021
    Inventors: Qianhe Zhou, Michael Bocker, David Simon Millan, Ho Man Chan, Luis Soares, Matthew Russell Netherton, Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Francois Brucelle
  • Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids
    Patent number: 7994168
    Abstract: The invention relates to substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids, and to the physiologically tolerated salts thereof, processes for their preparation and their use as medicaments.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: August 9, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Petra Lennig, Siegfried Stengelin, Thomas Klabunde, Matthias Gossel, Pavel Safar, James Spoonamore, Gregory Merriman, Joseph T Klein, Brian Whiteley, Carolina Lanter, Kenneth Bordeau, Zhaoxia Yang, Martin Smrcina